RETROVIRAL-MEDIATED TRANSDUCTION OF P53 GENE INCREASES TGF-BETA EXPRESSION IN A HUMAN GLIOBLASTOMA CELL-LINE

被引:23
作者
FUJIWARA, T
MUKHOPADHYAY, T
CAI, DW
MORRIS, DK
ROTH, JA
GRIMM, EA
机构
[1] UNIV TEXAS,MD ANDERSON CANC CTR,DEPT TUMOR BIOL,HOUSTON,TX 77030
[2] UNIV TEXAS,MD ANDERSON CANCER CTR,DEPT THORAC SURG,HOUSTON,TX 77030
[3] UNIV TEXAS,MD ANDERSON CANC CTR,DEPT CARDIOVASC SURG,HOUSTON,TX 77030
关键词
D O I
10.1002/ijc.2910560614
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Transforming growth factor-beta (TGF-beta) has been implicated as a potent growth regulator; the degree of responses to it, whether positive or negative, generally correlates with the stage of cell differentiation in various cell types. We examined the effect of the p53 gene, which participates in the control of cell-cycle progression, on the expression of human TGF-beta. The human glioblastoma cell line SNB-19, which expresses the latent form of TGF-beta, was transfected with a retroviral vector containing wild-type p53 (wt-p53) or p53 with a mutation (mut-p53) at codon 273. Stable G418-resistant SNB-19 clones were isolated. The growth kinetics of wt-p53 transfectants were suppressed compared with those of parental cells, vector transfectants, or mut-p53 transfectants, as assayed by growth-curve measurements and H-3-thymidine incorporation; however, RNA dot blot and Western blot analyses demonstrated that wt-p53 and mut-p53 transfectants expressed higher amounts of TGF-beta 1 and TGF-beta 2 mRNA and intracellular TGF-beta isoform proteins, respectively, than parental cells. By means of the biological assay for active TGF-beta (Mv1Lu cell-growth-inhibition assay), we observed that both transfectants produced active TGF-beta, whereas the parental cells produced only the latent form. These results suggest that, while only the wt-p53 gene inhibits tumor-cell progression, both wt-p53 and codon 273-mutated p53 can cause increased TGF-beta expression. (C) 1994 Wiley-Liss, Inc.
引用
收藏
页码:834 / 839
页数:6
相关论文
共 31 条
[1]   AN ACTIVATED FORM OF TRANSFORMING GROWTH FACTOR-BETA IS PRODUCED BY COCULTURES OF ENDOTHELIAL-CELLS AND PERICYTES [J].
ANTONELLIORLIDGE, A ;
SAUNDERS, KB ;
SMITH, SR ;
DAMORE, PA .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1989, 86 (12) :4544-4548
[2]  
ASSOIAN RK, 1983, J BIOL CHEM, V258, P7155
[3]   CHROMOSOME-17 DELETIONS AND P53 GENE-MUTATIONS IN COLORECTAL CARCINOMAS [J].
BAKER, SJ ;
FEARON, ER ;
NIGRO, JM ;
HAMILTON, SR ;
PREISINGER, AC ;
JESSUP, JM ;
VANTUINEN, P ;
LEDBETTER, DH ;
BARKER, DF ;
NAKAMURA, Y ;
WHITE, R ;
VOGELSTEIN, B .
SCIENCE, 1989, 244 (4901) :217-221
[4]   WILD-TYPE BUT NOT MUTANT P53 IMMUNOPURIFIED PROTEINS BIND TO SEQUENCES ADJACENT TO THE SV40 ORIGIN OF REPLICATION [J].
BARGONETTI, J ;
FRIEDMAN, PN ;
KERN, SE ;
VOGELSTEIN, B ;
PRIVES, C .
CELL, 1991, 65 (06) :1083-1091
[5]   STABLE EXPRESSION OF THE WILD-TYPE P53 GENE IN HUMAN LUNG-CANCER CELLS AFTER RETROVIRUS-MEDIATED GENE-TRANSFER [J].
CAI, DW ;
MUKHOPADHYAY, T ;
LIU, YJ ;
FUJIWARA, T ;
ROTH, JA .
HUMAN GENE THERAPY, 1993, 4 (05) :617-624
[6]   THE TRANSFORMING GROWTH-FACTOR-BETA SYSTEM, A COMPLEX PATTERN OF CROSS-REACTIVE LIGANDS AND RECEPTORS [J].
CHEIFETZ, S ;
WEATHERBEE, JA ;
TSANG, MLS ;
ANDERSON, JK ;
MOLE, JE ;
LUCAS, R ;
MASSAGUE, J .
CELL, 1987, 48 (03) :409-415
[7]  
CONSTAM DB, 1992, J IMMUNOL, V148, P1404
[8]   MOLECULAR EVENTS IN THE PROCESSING OF RECOMBINANT TYPE-1 PRE-PRO-TRANSFORMING GROWTH FACTOR-BETA TO THE MATURE POLYPEPTIDE [J].
GENTRY, LE ;
LIOUBIN, MN ;
PURCHIO, AF ;
MARQUARDT, H .
MOLECULAR AND CELLULAR BIOLOGY, 1988, 8 (10) :4162-4168
[9]   RETINOIC ACID INDUCES TRANSFORMING GROWTH FACTOR-BETA-2 IN CULTURED KERATINOCYTES AND MOUSE EPIDERMIS [J].
GLICK, AB ;
FLANDERS, KC ;
DANIELPOUR, D ;
YUSPA, SH ;
SPORN, MB .
CELL REGULATION, 1989, 1 (01) :87-97
[10]   INHIBITION OF ENDOTHELIAL REGENERATION BY TYPE-BETA TRANSFORMING GROWTH-FACTOR FROM PLATELETS [J].
HEIMARK, RL ;
TWARDZIK, DR ;
SCHWARTZ, SM .
SCIENCE, 1986, 233 (4768) :1078-1080